DF
ABBV icon

Daviman Financial’s AbbVie ABBV Stock Holding History

Daviman Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$334K Sell
1,327
-224
-14% -$48.2K 0.18% 64
2026
Q1 		$337K Buy
1,551
+67
+5% +$14.9K 0.2% 63
2025
Q4 		$339K Buy
+1,484
New +$338K 0.2% 60

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Daviman Financial's ABBV Position: Q2 2026 in Review

Daviman Financial reduced its AbbVie (ABBV) stake by 14% in Q2 2026, selling an estimated $48.2K and leaving 1,327 shares worth $334K. The position accounts for 0.18% of the portfolio, ranked #64.

Daviman Financial first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. The position peaked at $339K in Q4 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Daviman Financial held 1,327 shares of AbbVie worth $334K as of Q2 2026.
  • Daviman Financial sold 224 AbbVie shares in Q2 2026, an estimated $48.2K.
  • AbbVie made up 0.18% of Daviman Financial's portfolio in Q2 2026, its #64 holding.
  • Daviman Financial first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • Daviman Financial's AbbVie position peaked at $339K in Q4 2025.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Daviman Financial's 13F filing for Q2 2026, filed 27 Jul 2026.